Travere Therapeutics, Inc.
US ˙ NasdaqGM ˙ US89422G1076

SecurityTVTX / Travere Therapeutics, Inc.
InstitutionProShare Advisors LLC
Latest Disclosed Ownership16,086 shares
Latest Disclosed Value $ 477,914
ProShare Advisors LLC reports 15.37% decrease in ownership of TVTX / Travere Therapeutics, Inc.

On April 24, 2026 - ProShare Advisors LLC filed a 13F-HR form disclosing ownership of 16,086 shares of Travere Therapeutics, Inc. (US:TVTX) valued at $477,915 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 6, 2026 disclosing 19,007 shares of Travere Therapeutics, Inc.. This represents a change in shares of -15.37% during the quarter. The current value of the position is $727,087 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-24 2026-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 16,086 -2,921 -15.37 478 -34.30 0.0007
2026-02-06 2025-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 19,007 756 4.14 726 66.51 0.0013
2025-11-06 2025-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 18,251 -3,143 -14.69 436 37.97 0.0009
2025-08-07 2025-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 21,394 -836 -3.76 317 -20.60 0.0006
2025-05-08 2025-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 22,230 -3,117 -12.30 398 -9.75 0.0009
2025-02-14 2024-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 25,347 6,896 37.37 442 70.93 0.0010
2024-11-14 2024-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 18,451 3,994 27.63 258 118.64 0.0006
2024-08-13 2024-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 14,457 -3,964 -21.52 119 -16.90 0.0003
2024-05-08 2024-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 18,421 1,557 9.23 142 -5.96 0.0004
2024-02-14 2023-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 16,864 2,497 17.38 152 17.97 0.0005
2023-11-13 2023-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 14,367 66 0.46 128 -41.55 0.0004
2023-08-10 2023-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 14,301 2,570 21.91 220 -16.73 0.0006
2023-05-26 2023-03-31 13F/A-1 TRAVERE THERAPEUTICS COM 89422G107 11,731 -1,495 -11.30 264 -5.40 0.0008
2023-05-12 2023-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 11,731 -1,495 264 0.0008
2023-02-02 2022-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 13,226 1,132 9.36 278 -6.71 0.0010
2022-11-07 2022-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 12,094 306 2.60 298 4.56 0.0011
2022-08-01 2022-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 11,788 -5,844 -33.14 285 -37.22 0.0009
2022-05-10 2022-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 17,632 -3,891 -18.08 454 -32.14 0.0010
2022-02-08 2021-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 21,523 1,085 5.31 669 34.88 0.0013
2021-11-12 2021-09-30 13F TRAVERE THERAPEUTICS COM 89422G107 20,438 -5,549 -21.35 496 30.87 0.0014
2021-08-13 2021-06-30 13F TRAVERE THERAPEUTICS COM 89422G107 25,987 3,231 14.20 379 -33.27 0.0011
2021-05-14 2021-03-31 13F TRAVERE THERAPEUTICS COM 89422G107 22,756 4,038 21.57 568 11.37 0.0018
2021-02-09 2020-12-31 13F TRAVERE THERAPEUTICS COM 89422G107 18,718 4,516 31.80 510 94.66 0.0019
2020-11-13 2020-09-30 13F RETROPHIN COM 761299106 14,202 1,670 13.33 262 2.34 0.0012
2020-08-03 2020-06-30 13F RETROPHIN COM 761299106 12,532 12,532 256 0.0014
2020-05-15 2020-03-31 13F RETROPHIN COM 761299106 0 -14,903 -100.00 0 -100.00
2020-02-12 2019-12-31 13F RETROPHIN COM 761299106 14,903 -1,443 -8.83 212 12.17 0.0010
2019-11-12 2019-09-30 13F RETROPHIN COM 761299106 16,346 -116 -0.70 189 -42.90 0.0011
2019-08-13 2019-06-30 13F RETROPHIN COM 761299106 16,462 -2,094 -11.28 331 -21.19 0.0020
2019-05-15 2019-03-31 13F RETROPHIN COM 761299106 18,556 225 1.23 420 1.20 0.0025
2019-02-14 2018-12-31 13F RETROPHIN COM 761299106 18,331 -3,104 -14.48 415 -32.63 0.0029
2018-11-14 2018-09-30 13F RETROPHIN COM 761299106 21,435 -614 -2.78 616 2.50 0.0042
2018-08-13 2018-06-30 13F RETROPHIN COM 761299106 22,049 -1,336 -5.71 601 14.91 0.0040
2018-05-14 2018-03-31 13F RETROPHIN COM 761299106 23,385 -3,467 -12.91 523 -7.60 0.0034
2018-02-14 2017-12-31 13F RETROPHIN COM 761299106 26,852 2,603 10.73 566 -6.29 0.0039
2017-11-13 2017-09-30 13F RETROPHIN COM 761299106 24,249 1,277 5.56 604 35.73 0.0056
2017-08-11 2017-06-30 13F RETROPHIN COM 761299106 22,972 -1,335 -5.49 445 -0.89 0.0044
2017-05-12 2017-03-31 13F/A-2 RETROPHIN COM 761299106 24,307 -6,438 -20.94 449 -22.85 0.0047
2017-05-08 2017-03-31 13F/A-1 RETROPHIN COM 761299106 24,307 0 449 0.0047
2017-04-25 2017-03-31 13F RETROPHIN COM 761299106 24,307 449
2017-02-13 2016-12-31 13F RETROPHIN COM 761299106 30,745 4,004 14.97 582 -2.68 0.0064
2016-11-10 2016-09-30 13F RETROPHIN COM 761299106 26,741 -4,989 -15.72 598 5.84 0.0084
2016-08-12 2016-06-30 13F RETROPHIN COM 761299106 31,730 425 1.36 565 32.01 0.0073
2016-05-06 2016-03-31 13F RETROPHIN COM 761299106 31,305 -2,854 -8.36 428 -35.05 0.0059
2016-02-05 2015-12-31 13F RETROPHIN COM 761299106 34,159 3,559 11.63 659 6.29 0.0080
2015-11-06 2015-09-30 13F RETROPHIN COM 761299106 30,600 -1,745 -5.39 620 -42.16 0.0087
2015-08-11 2015-06-30 13F RETROPHIN COM 761299106 32,345 6,916 27.20 1,072 76.03 0.0148
2015-05-08 2015-03-31 13F RETROPHIN COM 761299106 25,429 25,429 0.00 609 0.0072
2014-11-06 2014-09-30 13F RETROPHIN COM 761299106 0 -10,366 -100.00 0 -100.00
2014-08-08 2014-06-30 13F RETROPHIN COM 761299106 10,366 10,366 122 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.